found that Glucagon-like Peptide-1 receptor agonists (GLP-1RA) can inhibit PAI-1 production in human vascular endothelial cells, which might improve endothelial cell dysfunction and premature atherosclerosis in type 2 diabetes patients (94). The gene discussed is SERPINE1; the disease is atherosclerosis.